Table 1 Preoperative demographic, clinical, and echocardiographic data
Variables | DeVega (n = 82) | MC3 ring (n = 23) | P value |
|---|---|---|---|
Age (years) | 48 ± 11.8 | 46.2 ± 11.2 | 0.53 |
Female gender | 53 (64.6%) | 14 (60.9%) | 0.74 |
NYHA class (III/IV) | 52 (63.4%) | 16 (69.6%) | 0.58 |
Atrial fibrillation | 45 (54.9%) | 13 (56.6%) | 0.88 |
Mitral valve disease | |||
Stenosis | 18 (23.2%) | 6 (26.1%) | 0.68 |
Insufficiency | 25 (30.5%) | 4 (17.4%) | 0.29 |
Stenosis and insufficiency | 38 (46.3%) | 13 (56.5%) | 0.38 |
Preoperative TR grade | 2.55 ± 0.61 | 2.39 ± 0.65 | 0.28 |
SPAP (mmHg) | 47.87 ± 14.70 | 52.21 ± 15.43 | 0.21 |
TA diameter (mm) | 34.62 ± 5.33 | 34.56 ± 5.56 | 0.96 |
TAPSE (mm) | 18.23 ± 3.11 | 17.13 ± 2.76 | 0.12 |
LAD (mm) | 42.97 ± 4.10 | 42.13 ± 4.33 | 0.39 |
LVEDD (mm) | 42.34 ± 2.37 | 42.08 ± 2.87 | 0.66 |
LVESD (mm) | 34.32 ± 1.79 | 34.21 ± 1.47 | 0.78 |
LVEF (%) | 55.73 ± 8.93 | 55.13 ± 9.45 | 0.77 |